EcoDrugPlus

Ribosomal Protein L22

Ensembl ID : ENSPLOG00000007126
Gene Symbol: RPL22
4 Cross references
94 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSPLOG00000007063
Gene Symbol: RPL23
4 Cross references
19 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSPLOG00000018595
Gene Symbol: RPL24
4 Cross references
302 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSPLOG00000015036
Gene Symbol: RPL26
3 Cross references
125 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSPLOG00000010254
Gene Symbol: RPL27
4 Cross references
213 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSPLOG00000004565
Gene Symbol: RPL3
4 Cross references
277 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSPLOG00000001870
Gene Symbol: RPL32
4 Cross references
137 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSPLOG00000014664
Gene Symbol: RPL35
4 Cross references
247 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSPLOG00000019470
Gene Symbol: RPL36A
2 Cross references
66 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSPLOG00000000332
Gene Symbol: RPL37
2 Cross references
122 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSPLOG00000021827
Gene Symbol: RPL37A
4 Cross references
33 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPLOG00000005945
Gene Symbol: RPL38
4 Cross references
194 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).